Concepedia

E Douglas Kramer

ED

Statistics

Publications

7

Citations

1K

H-Index

7

Active since

1984

Affiliations

Stanley Foundation(Current)

Liga Nacional Contra el Cáncer

Morgan Stanley (United States)

Centro Universitario de Occidente

Instituto de Oncología de Rosario

E Douglas Kramer is an author at Stanley Foundation specializing in medicine, chemotherapy, and oncology.

Publications per year

1984–2022

7

Publications

7

Protective Effect of the Bispiperazinedione ICRF-187 against Doxorubicin-Induced Cardiac Toxicity in Women with Advanced Breast Cancer

James L. Speyer, Michael D. Green, E Douglas Kramer et al. · New England Journal of Medicine · 1988 · 355 citations

, , +17

ICRF-187 permits longer treatment with doxorubicin in women with breast cancer.

James L. Speyer, M D Green, Anne Zeleniuch‐Jacquotte et al. · Journal of Clinical Oncology · 1992 · 323 citations

, , +17

The value of radionuclide angiography as a predictor of perioperative myocardial infarction in patients undergoing abdominal aortic aneurysm resection

Peter F. Pasternack, Anthony M. Imparato, George Bear et al. · Journal of Vascular Surgery · 1984 · 140 citations · Full text

, , +11

The value of the radionuclide angiogram in the prediction of perioperative myocardial infarction in patients undergoing lower extremity revascularization procedures.

Pasternack Pf, Imparato Am, Riles Ts et al. · PubMed · 1985 · 132 citations

, , +13

A prospective randomized trial of ICRF-187 for prevention of cumulative doxorubicin-induced cardiac toxicity in women with breast cancer

James L. Speyer, M.D. Green, Joseph J. Sanger et al. · Cancer Treatment Reviews · 1990 · 25 citations

, , +13

1–5 of 7